REPLY
4.5.2022 09:32:07 CEST | Business Wire | Press release
Reply announced today that it has implemented a Quantum Inspired Algorithm, that can be used on both Quantum and traditional computers, for Enel , one of the leading global operators in the electricity and renewable energy production sector. The innovative solution allows Enel to quickly identify the optimal allocation of maintenance activities for operating units distributed across the areas where it operates.
For Enel, which boasts a presence in over 30 countries around the world, a network of over 2.2 million kilometres and 74 million end users, it is essential to coordinate the crews and the allocation and planning of the objectives of the operating units scattered throughout the various territories to guarantee the highest level of service for its customers. Hence the need for operational planning that is as efficient as possible.
The solution developed by Reply is based on the QUBO (Quadratic Unconstrained Binary Optimisation ) mathematical model and can be performed effectively by quantum hardware, known as Quantum Processing Units or QPUs , as well as by classical hardware, known as Graphics Processing Units or GPUs .
Extracting the maximum potential of the GPUs was possible thanks to the MegaQUBO accelerator, a software solution developed by Data Reply to speed up the implementation of Quantum Inspired Optimisation projects . MegaQUBO is a solution certified by Amazon Web Services for use on the AWS Cloud, through the “FTR - Foundational Technical Review” process, which ensures that the software adheres to AWS architectural best practices.
In addition to identifying the optimal allocation of activities, the algorithm created for Enel is also able to calculate the optimal travel routes to reach work destinations, minimising travel times and distances and maximising the time available for actual maintenance work. This leads to a significant increase in productivity and a substantial reduction in operating costs, as well as the corresponding environmental impact .
“Quantum computing makes it possible to solve challenges considered insurmountable until just a few years ago” comments Filippo Rizzante, CTO of Reply . “As we were able to successfully demonstrate based on our experience with Enel, the use of quantum algorithms to solve optimisation problems allows us to obtain significant benefits, not only in the quality of the results, but also in the reduction of processing times. At Reply, we are thus closely exploring different areas in which we can exploit the potential of quantum computing to obtain insights from extremely large and constantly updated databases.”
“The need to implement optimisation strategies on increasingly large territorial areas has correspondingly enhanced the complexity of the problem, to the point that a new and innovative approach was needed”, explains Fabio Veronese, Head of Infrastructure & Networks Digital Hub at ENEL . “The Quantum Inspired approach implemented together with Reply has made it possible to achieve significant and concrete results in the field, and is applicable to both known problems, as well as to new business contexts.”
Reply
Reply [MTA, STAR: REY, ISIN: IT0005282865] specialises in the design and implementation of solutions based on the new communication channels and digital media. Through its network of highly specialised companies, Reply partners with major European corporations in the telecoms and media, industry and services, banking and insurance, and public administration sectors, to devise and develop business models built on the new paradigms of artificial intelligence, big data, cloud computing, digital media, and the Internet of Things. Reply’s services include: Consulting, Systems Integration, and Digital Services. www.reply.com
Data Reply
Data Reply is the Reply group company that specialises in Big Data Analytics, Artificial Intelligence, and Quantum Computing. Thanks to multidisciplinary teams of specialists in Big Data Engineering, Data Science, Intelligent Process Automation, and Quantum & Accelerated Computing, Data Reply supports companies operating in different industrial sectors in their process optimisation journey, through the design and implementation of advanced Quantum Computing solutions and Machine Learning and Artificial Intelligence models. www.data.reply.com
Enel
Enel is the largest European utility by ordinary EBITDA and is present in over 30 countries worldwide, producing energy with around 88 GW of installed capacity. Enel distributes electricity through a network of over 2.2 million kilometres, and with approximately 74 million corporate and domestic end users worldwide, the Group boasts the largest customer base among European competitors. Within the Enel Group, Enel Green Power is the largest private operator in the renewable energy sector in the world, with a managed capacity of over 46 GW from wind, solar, geothermal and hydroelectric plants in Europe, the Americas, Africa, Asia and Oceania. Enel X, Enel’s global advanced energy services business line, is a world leader in demand response, with a total capacity of over 6.3 GW managed globally. The company has installed 110 MW of storage capacity and, in the electric mobility sector, over 100,000 charging points for public and private electric vehicles worldwide.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220504005064/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off
Speech Processing Solutions Launches Philips SpeechLive Legal AI Assistant for Faster, More Accurate Legal Document Creation5.8.2026 15:37:00 CEST | Press release
The new SpeechLive Legal AI Assistant reduces the administrative burden on legal professionals through customizable document drafting powered by speech recognition tuned for legal terminology Speech Processing Solutions, the global leader in AI-assisted professional dictation and documentation solutions sold under the Philips brand, today announced the Philips SpeechLive Legal AI Assistant. The new solution transforms voice recordings, dictation and uploaded sources into structured, ready-to-review legal documents, helping legal professionals work faster while retaining control of the final draft. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805997413/en/ The new Philips SpeechLive Legal AI Assistant is designed for turning conversations into ready-to-review legal document drafts. SpeechLive Legal significantly reduces the time needed to transform voice input into structured legal documentation, delivering consistent an
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
